Found 31 matching trials
GutHeart: Targeting Gut Microbiota to Treat Heart Failure
PHASE2The objective of this trial is to study the effect of targeting the gut mic...
Location
Oslo University Hospital - Rikshospitalet
A Longitudinal Study to Identify IBS Phenotypes Using Fecal Microbiota and Hydrogen Breath Testing
PHASE4Diarrhea-predominant irritable bowel syndrome (IBS-D) is a highly prevalent...
Location
University of Michigan
Rifaximin Versus Norfloxacin in Spontaneous Bacterial Peritonitis
PHASE3Background
Prophylaxis of SBP is indicated in three high-risk populations:...
Location
Ospedali Riuniti Foggia
Weight Loss Benefits of Rifaximin in an Intermittent Fasting Diet
PHASE4The epidemic of overweight and obese patients presents a major challenge in...
Location
Bayhealth Medical Center- Dover Family Physicians and GI Consultants Office
A Multicentre Study on Rifaximin in Post-operative Endoscopic Crohn's Disease Recurrence Prevention
PHASE2Crohn's Disease (CD) is a chronic pathology characterized by exacerbations ...
Location
Humanitas Clinical Research Center
Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis
PHASE4This investigational trial will be assessing the effect of rifaximin on pat...
Location
Copenhagen University hospital Hvidovre
Bedside Ultrasound Assisted Pediatric Lumbar Puncture
NAThis is a prospective, randomized study evaluating the efficacy of bedside ...
Location
Advocate Christ Medical Center
Rifaximin Reduces the Complications of Decompensated Cirrhosis: a Randomized Controlled Trial
PHASE4Cirrhotic patients are predisposed to intestinal dysmotility, bacterial ove...
Location
Shanghai changzheng Hospital
Rifaximin Versus No Intervention for the Treatment of IgG/IgA (Non-IgM) Monoclonal Gammopathy of Undetermined Significance
PHASE2This phase II trial compares the effect of rifaximin to no intervention for...
Location
Fred Hutch/University of Washington Cancer Consortium
Efficacy of Rifaximin in Preventing Campylobacteriosis
PHASE2This study is a randomized, double-blinded, placebo-controlled, in-patient ...
Location
Center for Immunization Research, Johns Hopkins Bloomberg School of Public Heatlh